Novartis Wants Atty DQ'd From MS Drug Patent Row In Del.
Novartis Pharmaceuticals Corp. asked a Delaware federal court to disqualify a lawyer representing another pharmaceutical company that has filed a patent infringement suit against it related to a multiple sclerosis drug,...To view the full article, register now.
Already a subscriber? Click here to view full article